BA
CRL icon

Boston Advisors’s Charles River Laboratories CRL Stock Holding History

Boston Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,465
Closed -$708K – 641
2017
Q4 		$708K Buy
+6,465
New +$704K 0.02% 434
2017
Q2 		– Sell
-9,580
Closed -$862K – 649
2017
Q1 		$862K Sell
9,580
-12,035
-56% -$1.02M 0.02% 379
2016
Q4 		$1.65M Buy
21,615
+1,650
+8% +$125K 0.04% 309
2016
Q3 		$1.66M Buy
19,965
+15,895
+391% +$1.33M 0.04% 298
2016
Q2 		$336K Buy
+4,070
New +$335K 0.01% 574

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return